Innophos Holdings, Inc. (IPHS) Given Average Rating of “Buy” by Brokerages

Shares of Innophos Holdings, Inc. (NASDAQ:IPHS) have been given an average broker rating score of 2.00 (Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation and one has given a strong buy recommendation to the company.

Zacks has also assigned Innophos an industry rank of 67 out of 265 based on the ratings given to related companies.

A number of research firms have commented on IPHS. Zacks Investment Research downgraded shares of Innophos from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 4th. KeyCorp reiterated a “hold” rating on shares of Innophos in a report on Wednesday, November 1st.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Old Mutual Global Investors UK Ltd. acquired a new stake in Innophos during the 3rd quarter worth $109,000. Public Employees Retirement System of Ohio increased its stake in shares of Innophos by 5.9% during the second quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock worth $124,000 after acquiring an additional 157 shares during the period. Macquarie Group Ltd. acquired a new position in shares of Innophos during the third quarter worth about $193,000. Piedmont Investment Advisors LLC acquired a new position in shares of Innophos during the third quarter worth about $209,000. Finally, Pacad Investment Ltd. increased its stake in shares of Innophos by 19.5% during the second quarter. Pacad Investment Ltd. now owns 4,900 shares of the specialty chemicals company’s stock worth $215,000 after acquiring an additional 800 shares during the period. Institutional investors and hedge funds own 94.46% of the company’s stock.

Shares of Innophos (NASDAQ IPHS) traded down $0.13 during trading hours on Monday, hitting $46.20. The company’s stock had a trading volume of 133,200 shares, compared to its average volume of 116,169. Innophos has a fifty-two week low of $41.66 and a fifty-two week high of $58.22. The stock has a market capitalization of $902.24, a price-to-earnings ratio of 18.78 and a beta of 0.86. The company has a quick ratio of 1.49, a current ratio of 2.86 and a debt-to-equity ratio of 0.83.

Innophos (NASDAQ:IPHS) last announced its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.06. The business had revenue of $184.00 million during the quarter, compared to analyst estimates of $179.33 million. Innophos had a return on equity of 13.90% and a net margin of 6.19%. The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.69 earnings per share. analysts expect that Innophos will post 2.5 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be issued a dividend of $0.48 per share. The ex-dividend date is Thursday, November 16th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.16%. Innophos’s dividend payout ratio is currently 88.48%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://weekherald.com/2017/12/04/innophos-holdings-inc-iphs-given-average-rating-of-buy-by-brokerages.html.

Innophos Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Get a free copy of the Zacks research report on Innophos (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply